Sonogen is working to commercialize a next-generation ultrasonic bone fracture healing device, with a patent-pending acoustic shear wave signal that heals 30% faster than the current standard of care, and built-in usage and fracture healing monitoring. Our technology is protected by a cloud of patents, with confirmed freedom to operate. Investors in this round receive a 33-50% BIITC rebate from the state of Maryland.